Risperidone-Associated Diffuse Myalgia in a 5-Year-Old Child With Attention-Deficit/Hyperactivity Disorder: A Rare Tolerability-Limiting Adverse Effect

American Journal of Therapeutics · Published 2026-07-31 · DOI 10.1097/mjt.0000000000002197

Authors (2)

Mehri Durak, Halenur Teke

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Durak, M., Teke, H. (2026). Risperidone-Associated Diffuse Myalgia in a 5-Year-Old Child With Attention-Deficit/Hyperactivity Disorder: A Rare Tolerability-Limiting Adverse Effect. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0000000000002197

Related articles

• Successful Treatment of Acrodermatitis Continua of Hallopeau With Upadacitinib · American Journal of Therapeutics · 2026 · Same journal
• Right Side Accessory Pathway Mediated Cardiomyopathy Treated with Amiodarone: First Adult Case Report · American Journal of Therapeutics · 2026 · Same journal
• Functional Recovery After Multimodal Noninvasive Neuromodulation for Multimorbid PTSD, Bipolar Mania With Psychosis, and Psoriatic Arthritis · American Journal of Therapeutics · 2026 · Same journal
• Blood Pressure Targets in Thoracic Aortic Disease: A Practical Comparison of ACC/AHA Guidance and Post-2024 European Guidelines · American Journal of Therapeutics · 2026 · Same journal
• Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study · American Journal of Therapeutics · 2026 · Same journal
• Percutaneous Myocardial Revascularization in High- and Very High-Risk Non-ST Elevation Acute Coronary Syndromes: Real-World Insights From Two University Hospitals in Germany and Romania · American Journal of Therapeutics · 2026 · Same journal
• Outcomes With Peptide Receptor Radionuclide Therapy in Patients With Pheochromocytoma/Paraganglioma: A Center of Excellence Experience · American Journal of Therapeutics · 2026 · Same journal
• Abrocitinib as a Novel Therapeutic Option for Elastolytic Giant Cell Granuloma: A Case Report · American Journal of Therapeutics · 2026 · Same journal
• Salvage Therapy With Upadacitinib for Tofacitinib-Refractory Scarring Alopecia in an Asian Patient: Role of JAK1 Selective Inhibition · American Journal of Therapeutics · 2026 · Same journal
• Clozapine-Induced Pisa Syndrome During Lithium Treatment in a Patient With Bipolar Disorder and Methamphetamine Use Disorder · American Journal of Therapeutics · 2026 · Same journal